Answers are grounded in this paper and cite their sources.
Determining mutations in the NAT2 gene enabled the identification of the INH acetylation type in patients and the genotyping results were consistent with the phenotype determined by methods of measurement of drug bioavailability.
No takes yet. Share an insight, caveat, or question.
Zabost et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: